Literature DB >> 24061696

Transperineal template-guided biopsy for diagnosis of prostate cancer in patients with at least two prior negative biopsies.

Tobias Klatte1, Natalia Swietek, Georg Schatzl, Matthias Waldert.   

Abstract

OBJECTIVE: To evaluate the prostate cancer (PCa) detection rate, PCa location, PCa significance and complications of a standardized 24-core template-guided transperineal biopsy (TPB) approach in patients with at least two negative transrectal biopsies.
METHODS: We prospectively recruited 50 men who had at least two negative transrectal ultrasound-guided extended biopsies in the past 24 months, a prostate-specific antigen (PSA) < 20 ng/mL, a prostate volume < 100 mL, and life expectancy of at least 90 % at 10 years. All patients underwent a standardized 24-core template-guided TPB biopsy. The PCa detection rate, PCa location, PCa significance, and complications were recorded.
RESULTS: Median age was 57.5 years and the median PSA level was 7.3 ng/ml. PCa was detected in 24 patients (48 %). The anterior zone was involved in 16 (32 %) PCa. Six PCa (25 %) were insignificant. Biopsy related complications occurred in 2 patients (4 %).
CONCLUSIONS: A 24-core TPB is a safe procedure with a high PCa detection rate. Few of the detected PCa are clinically insignificant. Men with at least two negative transrectal biopsies may be counseled to undergo TPB.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24061696     DOI: 10.1007/s00508-013-0421-4

Source DB:  PubMed          Journal:  Wien Klin Wochenschr        ISSN: 0043-5325            Impact factor:   1.704


  16 in total

Review 1.  The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma.

Authors:  Jonathan I Epstein; William C Allsbrook; Mahul B Amin; Lars L Egevad
Journal:  Am J Surg Pathol       Date:  2005-09       Impact factor: 6.394

2.  EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease.

Authors:  Axel Heidenreich; Joaquim Bellmunt; Michel Bolla; Steven Joniau; Malcolm Mason; Vsevolod Matveev; Nicolas Mottet; Hans-Peter Schmid; Theo van der Kwast; Thomas Wiegel; Filliberto Zattoni
Journal:  Eur Urol       Date:  2010-10-28       Impact factor: 20.096

3.  The optimal rebiopsy prostatic scheme depends on patient clinical characteristics: results of a recursive partitioning analysis based on a 24-core systematic scheme.

Authors:  Vincenzo Scattoni; Marco Raber; Umberto Capitanio; Firas Abdollah; Marco Roscigno; Diego Angiolilli; Carmen Maccagnano; Andrea Gallina; Antonio Saccà; Massimo Freschi; Claudio Doglioni; Patrizio Rigatti; Francesco Montorsi
Journal:  Eur Urol       Date:  2011-07-30       Impact factor: 20.096

4.  Age-specific PCA3 score reference values for diagnosis of prostate cancer.

Authors:  Tobias Klatte; Matthias Waldert; Michela de Martino; Georg Schatzl; Christine Mannhalter; Mesut Remzi
Journal:  World J Urol       Date:  2011-08-30       Impact factor: 4.226

Review 5.  Optimizing performance and interpretation of prostate biopsy: a critical analysis of the literature.

Authors:  Felix K-H Chun; Jonathan I Epstein; Vincenzo Ficarra; Stephen J Freedland; Rodolfo Montironi; Francesco Montorsi; Shahrokh F Shariat; Fritz H Schröder; Vincenzo Scattoni
Journal:  Eur Urol       Date:  2010-09-04       Impact factor: 20.096

Review 6.  Epstein criteria for insignificant prostate cancer.

Authors:  Sheng F Oon; R William Watson; John J O'Leary; John M Fitzpatrick
Journal:  BJU Int       Date:  2011-02-14       Impact factor: 5.588

7.  Office based transrectal saturation biopsy improves prostate cancer detection compared to extended biopsy in the repeat biopsy population.

Authors:  Osama M Zaytoun; Ayman S Moussa; Tianming Gao; Khaled Fareed; J Stephen Jones
Journal:  J Urol       Date:  2011-07-23       Impact factor: 7.450

8.  Prostate cancer detection rate in patients with repeated extended 21-sample needle biopsy.

Authors:  Jean-Louis Campos-Fernandes; Laurence Bastien; Nathalie Nicolaiew; Grégoire Robert; Stéphane Terry; Francis Vacherot; Laurent Salomon; Yves Allory; Dimitri Vordos; Andras Hoznek; René Yiou; Jean Jacques Patard; Claude Clément Abbou; Alexandre de la Taille
Journal:  Eur Urol       Date:  2008-06-23       Impact factor: 20.096

9.  A nomogram predicting 10-year life expectancy in candidates for radical prostatectomy or radiotherapy for prostate cancer.

Authors:  Jochen Walz; Andrea Gallina; Fred Saad; Francesco Montorsi; Paul Perrotte; Shahrokh F Shariat; Claudio Jeldres; Markus Graefen; Francois Bénard; Michael McCormack; Luc Valiquette; Pierre I Karakiewicz
Journal:  J Clin Oncol       Date:  2007-08-20       Impact factor: 44.544

10.  Prostate cancer detection rates in different biopsy schemes. Which cores for which patients?

Authors:  Luigi Cormio; Vincenzo Scattoni; Fabrizio Lorusso; Antonia Perrone; Giuseppe Di Fino; Oscar Selvaggio; Francesca Sanguedolce; Pantaleo Bufo; Francesco Montorsi; Giuseppe Carrieri
Journal:  World J Urol       Date:  2012-11-25       Impact factor: 4.226

View more
  4 in total

1.  Clinicopathologic characteristics of anterior prostate cancer (APC), including correlation with previous biopsy pathology.

Authors:  Martin J Magers; Tianyu Zhan; Aaron M Udager; John T Wei; Scott A Tomlins; Angela J Wu; Lakshmi P Kunju; Madelyn Lew; Felix Y Feng; Daniel A Hamstra; Javed Siddiqui; Arul M Chinnaiyan; Jeffrey S Montgomery; Alon Z Weizer; Todd M Morgan; Brent K Hollenbeck; David C Miller; Ganesh S Palapattu; Hui Jiang; Rohit Mehra
Journal:  Med Oncol       Date:  2015-10-06       Impact factor: 3.064

2.  Combined T2 and diffusion-weighted MR imaging with template prostate biopsies in men suspected with prostate cancer but negative transrectal ultrasound-guided biopsies.

Authors:  Nissar Sheikh; Cheng Wei; Magdalena Szewczyk-Bieda; Annie Campbell; Shaukat Memon; Stephen Lang; Ghulam Nabi
Journal:  World J Urol       Date:  2016-05-28       Impact factor: 4.226

Review 3.  Role of Prophylactic Antibiotics in Transperineal Prostate Biopsy: A Systematic Review and Meta-analysis.

Authors:  Spyridon P Basourakos; Mark N Alshak; Patrick J Lewicki; Emily Cheng; Michael Tzeng; Antonio P DeRosa; Mathew J Allaway; Ashley E Ross; Edward M Schaeffer; Hiten D Patel; Jim C Hu; Michael A Gorin
Journal:  Eur Urol Open Sci       Date:  2022-01-29

4.  Assessment of the Performance of Magnetic Resonance Imaging/Ultrasound Fusion Guided Prostate Biopsy against a Combined Targeted Plus Systematic Biopsy Approach Using 24-Core Transperineal Template Saturation Mapping Prostate Biopsy.

Authors:  Francis Ting; Pim J Van Leeuwen; James Thompson; Ron Shnier; Daniel Moses; Warick Delprado; Phillip D Stricker
Journal:  Prostate Cancer       Date:  2016-05-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.